Companies

Boston Scientific says its acquisition of Cortex, Inc., will complement electrophysiology portfolio with solution to advance the treatment of complex … continue reading “Boston Scientific to Acquire Atrial Fibrillation Tech Company Cortex, Inc.”

Boston Scientific Corporation tells us it has obtained CE mark for the ACURATE Prime™ Aortic Valve System. Indeed it is … continue reading “ACURATE Prime™, Boston Scientific’s New Aortic Valve System Gains CE Mark”

New funding will be used to support Jupiter Endovascular in its upcoming pivotal trial for Pulmonary Embolism. It will also … continue reading “Jupiter Endovascular Funding Means Green Light for Pulmonary Embolism Pivotal Trial”

The Emboliner “Protect the Head to Head” investigational device exemption (IDE) clinical trial has seen its one hundredth patient enrolled. … continue reading “Emboliner ® IDE Study 100 Patient Milestone”

Biosense Webster, Inc., has announced European CE mark approval of the VARIPULSE™ Platform. The approval covers the treatment of symptomatic drug refractory … continue reading “VARIPULSE™ Pulse Field Ablation (PFA) Platform Gains CE Mark”

Heart Valve Pioneer Foldax® Inc., will see its innovative TRIA™ polymer mitral surgical heart valves being manufactured in India. A newly … continue reading “Foldax Signs Indian Manufacturer to Help Expedite Mitral Valve Commercialization in the Country”

East of England – based Medovate Ltd. and JEB Technologies Ltd., have become part of the same group structure. In … continue reading “Medovate and JEB Technologies Join Forces”

A press release from the UK’s Association of British HealthTech Industries (ABHI) signals a warning for regulators and NHS procurement. … continue reading “ABHI Warns that Unworkable HealthTech Procurement Means 1 in 3 Companies have Chosen to Not Bid on Tenders”

The U.S. FDA has approved Medtronic’s Percept™ RC Deep Brain Stimulation (DBS) system. The rechargeable neurostimulator is the latest innovation … continue reading “FDA Approves Medtronic Percept™ RC DBS System with BrainSense™ technology”

The global drug eluting stent (DES) market size is expected to reach USD 13.65 billion by 2030, advancing at a … continue reading “Drug Eluting Stent Market Growth Predicted”

Medtronic plc says the US FDA has approved the Symplicity Spyral ™ renal denervation (RDN) system as an adjunct to … continue reading “Spyral ™ Gains FDA Approval”

Exoskeleton technologist, Ekso Bionics is acquiring the Human Motion and Control (HMC) Business Unit from Parker Hannifin Corporation. Parker Hannifin … continue reading “Ekso Bionics’ Exoskeleton Business Expands with Strategic Acquisition”

LimFlow SA has announced the appointment of Mike Mathias as Vice President of Commercial Operations. The company is a pioneer in … continue reading “New Commercial Operations VP for LimFlow”

Technological advancements such as Sky Medical Technology‘s wearable geko™ device mark a new era in the treatment of Venous Leg … continue reading “Venous Leg Ulcers; Economics and MedTech’s Answers”

Medtronic plc, has received U.S. FDA 510(k) clearance and Breakthrough Device designation for its novel LigaPASS™ 2.0 Ligament Augmentation System. … continue reading “FDA Clears First Spine Device for Ligament Augmentation”

Medtronic plc says the first patient implants in the TITAN 2 pivotal study will evaluate the safety and efficacy of … continue reading “Tibial Neuromodulation for OAB: First Patient Implants”